StockNews.com started coverage on shares of LifeVantage (NASDAQ:LFVN – Get Rating) in a research note issued to investors on Friday morning. The brokerage issued a buy rating on the stock.
LifeVantage Trading Down 3.3 %
NASDAQ LFVN opened at $3.82 on Friday. The firm's 50 day simple moving average is $4.29 and its 200 day simple moving average is $4.52. The firm has a market capitalization of $47.95 million, a price-to-earnings ratio of 15.92 and a beta of 1.21. LifeVantage has a 1 year low of $3.80 and a 1 year high of $8.02.
Get
LifeVantage alerts:
LifeVantage Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 15th. Stockholders of record on Friday, September 2nd will be issued a dividend of $0.03 per share. The ex-dividend date is Thursday, September 1st. This represents a $0.12 dividend on an annualized basis and a dividend yield of 3.14%. LifeVantage's dividend payout ratio (DPR) is currently 50.00%.
Institutional Trading of LifeVantage
Several large investors have recently bought and sold shares of the business. EP Wealth Advisors LLC acquired a new stake in LifeVantage in the first quarter valued at approximately $234,000. State Street Corp lifted its stake in shares of LifeVantage by 7.6% in the 1st quarter. State Street Corp now owns 46,191 shares of the company's stock valued at $220,000 after acquiring an additional 3,281 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of LifeVantage by 30.3% during the 1st quarter. American Century Companies Inc. now owns 46,016 shares of the company's stock valued at $219,000 after acquiring an additional 10,706 shares in the last quarter. O Shaughnessy Asset Management LLC grew its position in LifeVantage by 61.8% during the 2nd quarter. O Shaughnessy Asset Management LLC now owns 24,368 shares of the company's stock worth $106,000 after acquiring an additional 9,312 shares during the last quarter. Finally, Private Advisor Group LLC acquired a new position in LifeVantage in the 2nd quarter worth about $49,000. 29.54% of the stock is owned by institutional investors and hedge funds.
LifeVantage Company Profile
(Get Rating)
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.
Featured Stories
- Get a free copy of the StockNews.com research report on LifeVantage (LFVN)
- Why Trading Volume is Unusually High on These 3 Stocks
- Can NetApp Resume Its Rally After Strong Earnings Guidance?
- Three Reasons Why Medtronic Stock can be a Recession Winner
- Rivian Rising to the Challenge
- 3 Deflation Enablers Stocks that Can Thrive in a Recession
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.
